New depression drug zuranolone one step closer to FDA ruling

Nature Medicine explores the latest translational and clinical research news, with a New Drug Application from Sage Therapeutics and Biogen for their GABA receptor agonist. Nature Medicine explores the latest translational and clinical research news, with a New Drug Application from Sage Therapeutic...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature medicine 2023-05, Vol.29 (5), p.1032-1033
1. Verfasser:	Carvalho, Thiago
Format:	Artikel
Sprache:	eng
Schlagworte:	Agonists Biomedicine Cancer Research Depression - drug therapy Humans Infectious Diseases Metabolic Diseases Molecular Medicine Neurosciences News Pregnanes Pyrazoles Receptors Translation United States United States Food and Drug Administration γ-Aminobutyric acid
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Nature Medicine explores the latest translational and clinical research news, with a New Drug Application from Sage Therapeutics and Biogen for their GABA receptor agonist. Nature Medicine explores the latest translational and clinical research news, with a New Drug Application from Sage Therapeutics and Biogen for their GABA receptor agonist. Image credit: Denis Pobytov / DigitalVision Vectors / Getty
ISSN:	1078-8956 1546-170X
DOI:	10.1038/d41591-023-00032-8